US Patent 7655762 Monoclonal antibodies against ANGPTL4
Patent 7655762 was granted and assigned to Lexicon Pharmaceuticals, Inc. on February, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+275 characters)
Article
Patent abstract
Monoclonal antibodies that specifically bind to ANGPTL4 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL4 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
David Reed Powell0
E-Chiang Lee0
Gregory M. Landes0
Kyu Chung0
Ling Chen0
Seokjoo Hong0
Urvi Desai0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07655762 Monoclonal antibodies against ANGPTL4 US Patent 7655762 Monoclonal antibodies against ANGPTL4
Infobox
Patent Number
076557620
Patent Number
76557620
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076557620
Date of Patent
February 2, 2010
0Patent Application Number
113278440
Date Filed
January 6, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07655762 Monoclonal antibodies against ANGPTL4
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07655762
Date of patent
February 2, 2010
Patent application number
11327844
Date Filed
January 6, 2006
Patent primary examiner
Find more entities like US Patent 7655762 Monoclonal antibodies against ANGPTL4
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.